Information Journal Paper
APA:
Copy. (2017). Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy. NEUROLOGICAL SCIENCES, 38(1), 53-59. SID. https://sid.ir/paper/733551/en
Vancouver:
Copy. Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy. NEUROLOGICAL SCIENCES[Internet]. 2017;38(1):53-59. Available from: https://sid.ir/paper/733551/en
IEEE:
Copy, “Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy,” NEUROLOGICAL SCIENCES, vol. 38, no. 1, pp. 53–59, 2017, [Online]. Available: https://sid.ir/paper/733551/en